Cargando…

Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy

The only clinically accepted method of fertility preservation in young women facing gonadotoxic chemo- and/or radiotherapy for malignant or autoimmune diseases is cryopreservation of embryos or unfertilized ova, whereas cryopreservation of ovarian tissue for future reimplantation, or in vitro matura...

Descripción completa

Detalles Bibliográficos
Autor principal:	Blumenfeld, Zeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Fertility Preservation: Present Practice and Future Endeavors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710670/ https://www.ncbi.nlm.nih.gov/pubmed/31488958 http://dx.doi.org/10.1177/1179558119870163

Ejemplares similares

Fertility Preservation in Women With Malignancy: Future Endeavors
por: Blumenfeld, Zeev
Publicado: (2019)

Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study
por: Armuand, Gabriela, et al.
Publicado: (2020)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
por: Poggio, Francesca, et al.
Publicado: (2019)

A synopsis of global frontiers in fertility preservation
por: Ataman, L. M., et al.
Publicado: (2022)

Current status and reflections on fertility preservation in China
por: Zhang, Jiakai, et al.
Publicado: (2022)

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer
por: Kim, S. Samuel, et al.
Publicado: (2012)

Counseling young women with early breast cancer on fertility preservation
por: ter Welle-Butalid, M. E. (Elena), et al.
Publicado: (2019)

Preservation of fertility in female and male prepubertal patients diagnosed with cancer
por: Albamonte, María Itatí, et al.
Publicado: (2023)

Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
por: Lotz, Laura, et al.
Publicado: (2019)

Fertility Preservation in Women With Endometriosis
por: Llarena, Natalia C, et al.
Publicado: (2019)

Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in New York City
por: Voigt, Paxton E., et al.
Publicado: (2020)

Challenging cases in oncofertility: insights from a national specialized e-meeting for fertility preservation specialists
por: Khiat, Samuel, et al.
Publicado: (2021)

Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
por: Porcu, Eleonora, et al.
Publicado: (2019)

Contraceptive methods and fertility testing in young adult survivors of childhood cancer
por: Cherven, Brooke, et al.
Publicado: (2023)

Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
por: Boltežar, Lučka, et al.
Publicado: (2015)

Reproduction in life and death: should cancer patients with a poor prognosis be offered fertility preservation interventions?
por: Jones, Georgina L, et al.
Publicado: (2023)

The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment
por: Takae, Seido, et al.
Publicado: (2014)

Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour
por: Dunlop, C. E., et al.
Publicado: (2016)

Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspects
por: Ayuandari, Sarrah, et al.
Publicado: (2016)

Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency
por: Bastings, Lobke, et al.
Publicado: (2016)

Complete protection against cryodamage of cryopreserved whole bovine and human ovaries using DMSO as a cryoprotectant
por: Westphal, Johan R., et al.
Publicado: (2017)

Cryopreservation and transplantation of ovarian tissue: results from one center in the USA
por: Silber, Sherman J., et al.
Publicado: (2018)

Influence of graft size, histocompatibility,and cryopreservation on reproductive outcome following ovary transplantation in mice
por: Kolbe, T., et al.
Publicado: (2019)

Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation
por: Rodrigues, P., et al.
Publicado: (2020)

Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II
por: Salama, Mahmoud, et al.
Publicado: (2022)

Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway
por: Eijkenboom, Lotte, et al.
Publicado: (2021)

Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion
Publicado: (2021)

Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents
por: Maristany, Sumiko, et al.
Publicado: (2022)

Pediatric oncofertility care in limited versus optimum resource settings: results from 39 surveyed centers in Repro-Can-OPEN Study Part I & II
por: Salama, M, et al.
Publicado: (2022)

Clinical pregnancy in Turner syndrome following re-implantation of cryopreserved ovarian cortex
por: Dunlop, CE, et al.
Publicado: (2023)

Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer
por: Ortiz, Ester, et al.
Publicado: (2023)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

Setting Up a Cryopreservation Programme for Immature Testicular Tissue: Lessons Learned After More Than 15 Years of Experience
por: Braye, Aude, et al.
Publicado: (2019)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
por: Merkison, Jamie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7vmsdhqn19tvhqfelapfrpcilb